Wilbrandia ebracteata
Wilbrandia ebracteata · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Wilbrandia ebracteata is a botanical species recognized for its significant pharmacological potential in addressing various health conditions. Research focusing on its leaf extracts has identified the presence of bioactive chemicals known as cucurbitacins. Specifically, preparations using DCM, HEX, and chlorophyll-free MeOH have been utilized to isolate compounds like Cucurbitacin B. These substances demonstrate notable analgesic and antiulcer activities, making them subjects of intense scientific interest. Furthermore, the plant shows promise in modulating cell migration, inflammation, PGE2 levels, and the management of rheumatic disease.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Cucurbitaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Taxonomy
Wilbrandia ebracteata is a distinctive member of the kingdom Plantae. Within this vast biological realm, the species belongs to the class Equisetopsida. It is further categorized under the order Cucurbitales, showcasing its specific evolutionary path. This plant is a proud representative of the genus Wilbrandia. Finally, its botanical identity is solidified by its classification within the family Cucurbitaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Cucurbitales |
| Family | Cucurbitaceae |
| Genus | Wilbrandia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Wilbrandia ebracteata is a notable species primarily distributed throughout the diverse landscapes of Southern America. Within Brazil, its presence is widespread, spanning from the Southeast to the West-Central regions and throughout various southern territories. The plant's reach also extends into the southern reaches of the continent, specifically inhabiting Paraguay. Furthermore, its range encompasses the northeastern portions of Argentina. This broad geographic footprint highlights the plant's ability to thrive across multiple South American ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Wilbrandia ebracteata relies on an obligatory climbing habit to navigate its environment and reach the sunlight necessary for its survival.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Wilbrandia ebracteata is a medicinal plant from the Cucurbitaceae family that is traditionally utilized for its therapeutic properties. Research into its hydromethanol leaf extract has specifically focused on its potential antiulcer and analgesic activities. In experimental studies involving mice, the extract demonstrated significant antiulcerogenic effects by reducing lesion areas caused by ethanol-induced gastric damage. While the plant is popularly used as an analgesic, the specific leaf extract tested in these trials did not show activity in the writhing or tail-flick tests. Ultimately, the antiulcer activity is believed to be driven by flavonoids, which likely work by increasing gastric defensive factors.
Compounds
Wilbrandia ebracteata is a medicinal plant native to South America that has long been utilized in folk medicine to treat chronic rheumatic diseases. Scientific investigation has revealed that this plant contains cucurbitacins, which are key components within its dichloromethane fraction. These cucurbitacins appear to drive the plant's significant anti-inflammatory and analgesic properties. Specifically, the compounds demonstrate an ability to reduce articular pain by inhibiting nitric oxide release and selectively targeting the COX-2 enzyme. Such findings suggest that the bioactive cucurbitacins within the plant offer a promising natural pathway for managing inflammatory conditions without causing gastrointestinal toxicity.
Conditions
Wilbrandia ebracteata demonstrates significant medicinal properties by selectively inhibiting the activity of COX-2 while having no effect on COX-1. The plant's extracts also effectively reduce the release of nitric oxide into the joint exudate during inflammatory processes. Furthermore, it works to decrease the levels of PGE2 within exudate leakage, which contributes to its anti-inflammatory action. These physiological effects are complemented by an analgesic response that produces a dose-dependent reduction in abdominal contortions. Collectively, these mechanisms highlight the plant's potential for treating chronic rheumatic diseases.
Preparations
Wilbrandia ebracteata is processed into several distinct preparations for pharmacological study, including Cucurbitacin B and various chemical fractions. Researchers utilize DCM as a specific preparation to evaluate its significant anti-inflammatory properties. Additionally, the plant is prepared as HEX and DCM to test for protective anti-ulcerogenic effects in animal models. The MeOH extract and MeOH chlorophyll-free preparations are also used to investigate gastric protection against ethanol-induced ulcers. These diverse preparations allow for the identification of specific active principles within the plant.
Parts used
Wilbrandia ebracteata is a medicinal plant from the Cucurbitaceae family that utilizes its leaves for various therapeutic applications. Research indicates that the hydromethanol extract of these leaves possesses significant anti-ulcerogenic properties, particularly against ethanol-induced gastric damage. Phytochemical analysis reveals that the leaves are rich in bioactive compounds, including steroids, tannins, and various flavonoids. Specifically, seven distinct flavonoids were isolated from the leaf fractions, suggesting they are the primary constituents responsible for the plant's protective effects. These findings highlight the medicinal importance of the leaf as a natural source for managing gastric lesions and scavenging free radicals.